Sandoval TC, Gutiérrez MF, Fernández MRF, Vásquez ME, Moreno CG, Arenas R

Language: Spanish
References: 16
Page: 172-174
PDF size: 120.54 Kb.

ABSTRACT

Background: Chronic renal failure (crf) affects all bodily systems. Consequently, it may cause various nail conditions, both non-infectious and infectious, including onychomycosis.
Objective: To determine the incidence of onychomycosis in crf patients under hemodialysis.
Material and methods: This study involved 42 crf patients undergoing hemodialysis and concomitantly afflicted with nail changes suggestive of onychomycosis. Tests performed included koh 20% and mycobiotic agar. Diagnosis was confirmed by direct koh test.
Results: Twenty-four patients were diagnosed with onychomycosis (57%) and the causative agent was isolated in 10 instances (41.66%). Diabetes mellitus was confirmed in 10 individuals from this group (41.66%). The most frequent clinical form was distal lateral subungual onychomycosis (65%), with Trichophyton rubrum as the most commonly isolated microorganism (60%).
Conclusions: Over half the patients with crf undergoing hemodialysis developed onychomycosis. The concurrence of diabetes mellitus may increase the incidence of onychomycosis.

REFERENCES

1. Braun LA, Sood V, Hogue S, Lieberman B, Copley-Merriman C. “High burden and unmet patient needs in chronic kidney disease”. Int J NephrolRenovasc Dis 2012; 2: 151-163.

2. Pérez-Terrazas H, Treviño-Becerra A, Cervantes-Hernández J. “The Blueprint of the Mexican Official Norm for Peritoneal Dialysis”. Nefrología Mexicana 2002; 23: 69-72.

3. Gupta AK, Gupta M, Cardella CJ, Haberman HF. “Cutaneous Associations of Chronic Renal Failure and Dialysis”. Int J Dermatol 1986; 25: 498-504.

4. Mazuryk HA, Brodkin RH. “Cutaneous clues to renal disease”. Cutis 1991; 47: 241-248.

5. Picó MR, Lugo-Somolinos A, Sánchez JL, Burgos-Calderón R. “Cutaneous Alterations in Patients with Chronic Renal Failure”. Int J Dermatol 1992; 31: 860-863.

6. Fawcett RS, Hart TM, Linford S, Stulberg D. “Nail Abnormalities: Clues to Systemic Disease”. Am FamPhysician 2004; 69: 1417-1424.

7. “Guidelines of care for nail disorders. American Academy of Dermatology”. J Am AcadDermatol 1996; 34: 529-533.

8. Deshmukh SP, Sharma YK, Dash K, Chaudhari NC, Deo KS. “Clinicoepidemiological study of skin manifestations in patients of chronic renal failure on hemodialysis”. Indian Dermatol Online J 2013; 4: 18-21.

9. Thomas EA, Pawar B, Thomas A. “A prospective study of cutaneous abnormalities in patients with chronic kidney disease”. Indian J Nephrol 2012; 22: 116-120.

10. Robinson-Bostom L, DiGiovanna JJ. “Cutaneous manifestations of end-stage renal disease”. J Am Acad Dermatol 2000; 43: 975-986.

11. López-Ibarra MM, Ledesma-de-la-Torre CI. “Frecuencia de las alteraciones ungueales en los pacientes internados en las áreas clínicas del Hospital de Especialidades del Centro Médico Nacional La Raza”. Dermatología. Rev Mex 2003; 47: 71-76.

12. Kuvandik G, Cetin M, Genctoy G, Horoz M, Duru M, Akcalli C, Satar S, Kiykim AA, Kaya H. “The prevalence, epidemiology and risk factors for onychomycosis in hemodialysis patients”. BMC Infect Dis 2007; 7: 102.

13. Udayakumar P, Balasubramaian S, Ramalingam KS, Lakshmi C, Srinivas CR, Mathew AC. “Cutaneous manifestations in patients with chronic renal failure on hemodialysis”. Indian J Dermatol Venereol Leprol 2006; 72: 119-125.

14. Daniel CR III. “An Approach to Initial Examination of the Nail”. En: Nails: Therapy, Diagnosis, Surgery. Saunders 1997; p. 101-103.

15. Kaur R, Kashyap B, Balla P. “Onychomycosis – epidemiology, diagnosis and management”. Indian J Med Microbiol 2008; 26: 108-116.

16. Arenas R. “Dermatofitosis en México”. Rev Iberoam Micol 2002; 19: 63-67.